The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
Clinical trial NCT04377750 · UNKNOWN
Trial details
- NCT number
- NCT04377750
- Sponsor
- Hadassah Medical Organization
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-08
- Primary completion
- 2020-04-29
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.